Quantum BioPharma Ltd.
QNTM | NASDAQ
$3.73
+$0.12 (+3.32%)
Sep 22, 2026, 1:17 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -15.3M | -16.14M | -23.79M | -27.43M | -33.74M | -30.69M |
Interest Income | 236.08K | 572.89K | 786.36K | 367.74K | 1.29K | 3.69K |
Pretax Income | -26.96M | -14.92M | -18.23M | -26.7M | -33.94M | -28.45M |
Net Income | -26.18M | -14.2M | -17.9M | -23.61M | -35.29M | -31.8M |
Selling & General & Admin | 12.01M | 9.31M | 13.2M | 15.98M | 23.37M | 18.11M |
Research & Development | 2.76M | 6.08M | 3.86M | 6.91M | 6.33M | 7.83M |
Other Expenses | 530.75K | 742.8K | 6.73M | 4.54M | 4.05M | 4.75M |
Operating Expenses | 15.3M | 16.14M | 23.79M | 27.43M | 33.74M | 30.69M |
Interest Expense | 618.64K | 47.58K | 299 | 48.82K | 69.4K | 235.58K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.3M | 16.14M | 23.79M | 27.43M | 33.74M | 30.69M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.29M | 1.14M | 609.06K | 595.88K | 537.62K | 185.29K |
Shares Outstanding (Diluted) | 3.29M | 1.14M | 609.06K | 595.88K | 537.62K | 185.29K |
EPS (Basic) | -8.11 | -12.49 | -29.39 | -39.62 | -65.63 | -171.62 |
EPS (Diluted) | -8.11 | -12.49 | -29.39 | -39.62 | -65.63 | -171.62 |
EBITDA | -25.79M | -14.38M | -15.72M | -22.12M | -29.82M | -24.32M |
EBIT | -26.34M | -14.87M | -18.23M | -26.65M | -33.87M | -28.22M |
Depreciation & Amortization | 545.78K | 490.57K | 2.51M | 4.54M | 4.05M | 3.9M |
Add to Watchlist
Select watchlists to add or remove QNTM